NCT02610608

Medical Assistance for the Procreation and Risk of Thrombosis.

Assistance Médicale à la Procréation et Risque Thrombotique

• Status: Terminated
• Phase: —
• Study type: Observational
• Enrollment: 129 (actual)
• Sponsor: University Hospital, Brest · Academic / Other
• Sex: Female
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This study aims at evaluating clincal practice regarding prevention of arterial and venous thrombosis following ovarian stimulation. Secondary outcomes are : 1) to describe the incidence and risk factors of arterial and venous thrombosis in women undergoing assisted reproductive technology and 2)to identify the incidence and risk factors for ovarian hyperstimulation syndrome in these women

Detailed description

All women undergoing an assisted reproductive tecnology in order to receive an in vitro fertilization in French centers will be included in the study. These women will be followed up until 12 months after ovarian stimulation if they get pregnant or until 3 months if the stimulation does not lead to pregnancy. Risk factors for thrombosis and ovarian hyperstimulation syndrome will be collected in each woman. At each visit, women will be asked whether arterial and/or venous thrombosis had occured.

Conditions

• Ovarian Hyperstimulation Syndrome
• Cardiovascular Diseases
• Embolism and Thrombosis

Interventions

Type	Name	Description
OTHER	ovarian stimulation	evaluation of clincal practice regarding prevention of arterial and venous thrombosis following ovarian stimulation

Timeline

• Start date: 2016-02-02
• Primary completion: 2016-11-20
• Completion: 2016-11-20
• First posted: 2015-11-20
• Last updated: 2020-07-10

Locations

9 sites across 1 country: France